Ozempic
Page 7 of 9
LeadershipOzempic maker Novo Nordisk has a new goal for its leadership team: Make sure no more than 10% of your staff are stressed
By Orianna Rosa RoyleMarch 22, 2024
FinanceWeightWatchers, reeling from collapsing stock and Oprah’s departure in the age of Ozempic, vows to ‘prove the naysayers wrong’ and turn its fortunes around
By Amanda GerutMarch 14, 2024
RetailRebel investors want KitKat maker Nestlé to cut back on junk food—but the fortunes of its Mindful Chef brand suggest customers aren’t ready for a health kick
By Ryan HoggMarch 14, 2024
RetailWegovy and Ozempic have ignited a gold rush in pharma as well as an upsurge in fake ‘skinny jabs’, leading to surge in hospitalizations
By Ashleigh Furlong and BloombergMarch 13, 2024
LifestyleNovo Nordisk eclipses Tesla on positive trial results for a weight loss drug that may be more powerful than its own Wegovy
By Prarthana PrakashMarch 8, 2024
RetailNovo Nordisk’s Wegovy and Ozempic boom saved Denmark’s GDP from a no-growth 2023—and will help double its expected growth this year, country’s largest bank says
By Niclas Rolander and BloombergMarch 5, 2024
HealthA billion people worldwide are obese and Ozempic and other weight-loss drugs aren’t a solution, WHO says
By Naomi Kresge, Angela Feliciano and BloombergMarch 1, 2024
TechAll the tech layoffs are because AI is like ‘corporate Ozempic’—it trims the fat and you keep the fact you’re using it a secret, says marketing guru Scott Galloway
By Paolo ConfinoFebruary 29, 2024
By Madison Muller and BloombergFebruary 21, 2024
RetailNovo Nordisk’s CEO says he’s fielding calls from ‘scared’ junk food suppliers asking for advice over Ozempic surge
By Ryan HoggFebruary 8, 2024
RetailNovo Nordisk CEO says he was ‘surprised’ to see the popularity of weight-loss drugs in Europe—and people’s readiness to pay out of pocket for them
By Prarthana PrakashFebruary 5, 2024
RetailNovo Nordisk hits $500B market value, climbing closer to the $1T club as it forecasts Wegovy and Ozempic will juice another 29% jump in profits this year
By Ryan HoggJanuary 31, 2024
Most Popular
